Medifast Q3 revenue falls on fewer active earning coaches
MED•Medifast's third-quarter revenue fell 19.4% year over year to $72.05 million as active earning coaches dropped nearly 48%; the company reported a $17.51 million net loss and a $1.57 loss per share. It expects fourth-quarter revenue of $55 million to $75 million and 2026 revenue of $280 million to $300 million.
1. Quarterly results
Medifast said third-quarter revenue fell 19.4% year over year to $72.05 million, mainly because it had fewer active earning coaches. The coach count dropped nearly 48%, as the company cited client acquisition challenges and increased GLP-1 medication use. Medifast reported a net loss of $17.51 million and a loss per share of $1.57.
2. Company outlook
Medifast expects fourth-quarter revenue of $55 million to $75 million and income per share of $0.00 to $0.25. It expects 2026 revenue of $280 million to $300 million. The company said revenue per coach rose with network restructuring and a focus on productivity.
